Literature DB >> 8295105

Guided tissue regeneration using bioresorbable and non-resorbable devices: initial healing and long-term results.

J Gottlow1.   

Abstract

Studies on periodontal wound healing have resulted in the development of the treatment modality known as "guided tissue regeneration" (GTR) based on a principle of guiding the proliferation of the various periodontal tissue components during healing following periodontal surgery. The first report of a human tooth treated according to the principle of GTR was presented 10 years ago by Nyman et al. Since then numerous clinical studies and animal experiments have been performed bringing the concept of GTR to a clinical reality. We also know that the results obtained through GTR therapy can be maintained on a long-term basis. The first generation of GTR devices has been non-resorbable, which calls for a second surgical procedure. This is avoided when bioresorbable devices become available. This paper suggests some demands regarding safety and efficacy criteria for both non-resorbable and bioresorbable devices. Results from recent animal experiments and clinical studies following the use of a bioresorbable device in GTR therapy are presented.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8295105     DOI: 10.1902/jop.1993.64.11s.1157

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  32 in total

1.  Osteoblast proliferation and differentiation on a barrier membrane in combination with BMP2 and TGFβ1.

Authors:  Richard J Miron; Nikola Saulacic; Daniel Buser; Tateyuki Iizuka; Anton Sculean
Journal:  Clin Oral Investig       Date:  2012-06-06       Impact factor: 3.573

Review 2.  Growth factor delivery for oral and periodontal tissue engineering.

Authors:  Darnell Kaigler; Joni A Cirelli; William V Giannobile
Journal:  Expert Opin Drug Deliv       Date:  2006-09       Impact factor: 6.648

Review 3.  Evolution of Barrier Membranes in Periodontal Regeneration-"Are the third Generation Membranes really here?".

Authors:  George Sam; Baiju Radhamoni Madhavan Pillai
Journal:  J Clin Diagn Res       Date:  2014-12-05

4.  Clinical use of the resorbable bioscaffold poly lactic co-glycolic acid (PLGA) in post-extraction socket for maintaining the alveolar height: A prospective study.

Authors:  Nadeemul Hoda; Aamir Malick Saifi; Girish B Giraddi
Journal:  J Oral Biol Craniofac Res       Date:  2016-04-19

5.  Comparative evaluation of coronally advanced flap with and without Biomesh® membrane for the treatment of localized gingival recession defects - a clinical study.

Authors:  Akansha Sharma; Amit Wadhawan
Journal:  J Med Life       Date:  2022-05

6.  Plain and drug loaded polyphosphazene membranes and microspheres in the treatment of rabbit bone defects.

Authors:  P Passi; A Zadro; F Marsilio; S Lora; P Caliceti; F M Veronese
Journal:  J Mater Sci Mater Med       Date:  2000-10       Impact factor: 3.896

7.  Vibrational and thermal study on the in vitro and in vivo degradation of a bioabsorbable periodontal membrane: Vicryl Periodontal Mesh (Polyglactin 910).

Authors:  P Taddei; P Monti; R Simoni
Journal:  J Mater Sci Mater Med       Date:  2002-01       Impact factor: 3.896

8.  Polymer-Based Honeycomb Films on Bioactive Glass: Toward a Biphasic Material for Bone Tissue Engineering Applications.

Authors:  A Deraine; M T Rebelo Calejo; R Agniel; M Kellomäki; E Pauthe; M Boissière; J Massera
Journal:  ACS Appl Mater Interfaces       Date:  2021-06-15       Impact factor: 9.229

Review 9.  The role of barrier membranes for guided bone regeneration and restoration of large bone defects: current experimental and clinical evidence.

Authors:  Rozalia Dimitriou; George I Mataliotakis; Giorgio Maria Calori; Peter V Giannoudis
Journal:  BMC Med       Date:  2012-07-26       Impact factor: 8.775

10.  In vitro evaluation of various bioabsorbable and nonresorbable barrier membranes for guided tissue regeneration.

Authors:  Adrian Kasaj; Christoph Reichert; Hermann Götz; Bernd Röhrig; Ralf Smeets; Brita Willershausen
Journal:  Head Face Med       Date:  2008-10-14       Impact factor: 2.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.